Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Julio Rodríguez-Iglesias"'
Autor:
Matilde Salcedo, Carmen Hinojo, Yolanda Blanco, Belen García-Montesinos, Carlos López, Maria Eugenia Vega-Villegas, Noelia Vega, Jaime Sanz-Ortiz, Marta López-Brea, Fe García-Reija, Adolfo del Valle, Fernando Rivera, Julio Rodríguez-Iglesias, Antonio Rubio, Miguel Angel Alonso-Bermejo, Raul Marquez, Sara López-Tarruella
Publikováno v:
Acta Oncologica. 47:1584-1589
Standard treatment of patients with T4b squamous cell head and neck cancer (T4b-SCHNC) is concomitant chemo-radiotherapy (CT-RT). Recent Phase III trials with Taxane containing induction chemotherapy (IC) suggest that IC could also play a role in thi
Autor:
M. Eugenia Vega-Villegas, Julio Rama, Jaime Sanz-Ortiz, Dolores Isla, Ramón C. Saiz-Bustillo, Belen García-Montesinos, Piedad Galdós, Marta Mayorga, Adolfo del Valle, Fernando Rivera, Julio Rodríguez-Iglesias, Jose I. Mayordomo, Marta López-Brea, Fe García-Reija, Antonio Rubio
Publikováno v:
Cancer chemotherapy and pharmacology. 62(2)
We conducted a multicentric randomized phase II trial comparing 5-FU continuous infusion (PF) and cisplatin, UFT and vinorelbine (UFTVP) as induction chemotherapy (IC) in locally advanced squamous cell head and neck cancer (LA-SCHNC). Primary objecti
Autor:
Jaime Sanz-Ortiz, A. del Valle, Belen García-Montesinos, M. F. García Reija, Maria Eugenia Vega-Villegas, Fernando Rivera, Marta López-Brea, Julio Rodríguez-Iglesias, Antonio Rubio, Carlos F. Lopez
Publikováno v:
Journal of Clinical Oncology. 25:16517-16517
16517 Background: Although standard treatment of patients with T4b Squamous Cell Head and Neck Cancer (T4b-SCHNC) for the last decade has been concomitant Chemo-Radiotherapy (CT-RT), recent Phase III trials with new Induction Chemotherapy (IC) regime